Found 9 matching trials
ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
PHASE2This is a phase II multicentre, uncontrolled trial including patients ≤ 40 ...
Location
I.R.C.C. - Unit of Medical Oncology
Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
N/AThis study is an observational safety surveillance study designed to prospe...
Location
AKH Wien Universitätsklinik für Innere Medizin I Klinische Abteilung für Onkologie
A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)
PHASE2This is a Bayesian designed multi-arm, multi-centre, open label phase II st...
Location
Pediatric Hematology and Oncology, University Hospital Münster
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
PHASE2Trial evaluating the impact on efficacy of mifamurtide as add-on treatment ...
Status
Active Not Recruiting
Location
CHU Amiens-Picardie - Service d'oncologie hématologie pédiatrique
Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study
N/AInternational, multicenter retrospecitve biological study...
Location
SSD Chemioterapia dei tumori dell'apparato locomotore
Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma
PHASE2Prospective, open, interventional, randomized, non-commercial trial...
Location
Mother and Child Institute
ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities
N/APost-authorization, observational, multicenter and prospective study in pat...
Location
Complejo Hospitalario Universitario de Santiago
Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma
N/AThe purpose of this study was to collect information regarding the safety a...
Location
Memorial Sloan-Kettering Cancer Center
Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
N/AThis expanded access protocol will allow access to treatment with L-MTP-PE ...
Location
Memorial Sloan Kettering Cancer Center (All Protocol Activities)